Mobius Medical Systems recently released DoseLab version 6.7. This new release adds significant features to the quality assurance (QA) software, including task scheduling and monitoring, role-based control and enhanced Microsoft Excel integration.

CMS, Medicare Advantage, Value-Based Insurance Design model, VBID, chronic conditions

The Centers for Medicare & Medicaid Services (CMS) announced the creation of the Medicare Advantage Value-Based Insurance Design Model, designed to improve care and reduce costs in Medicare Advantage plans.

Results of the PLATFORM trial indicate fractional flow reserve computed tomography (FFR-CT) can obviate the need for invasive tests in up to 61 percent of patients with chest pain and suspected coronary artery disease. The results were presented at the European Society of Cardiology (ESC) Congress 2015.

Linköping University Hospital in Sweden has installed SyMRI Neuro from SyntheticMR in order to improve the follow-up of patients with multiple sclerosis (MS).

Significant national and international momentum is building to include a proton therapy unit as part of the planned expansion of SAHMRI, South Australia’s Health and Medical Research Institute. It would be the first facility in the Southern Hemisphere to deliver proton therapy.

Varian Medical Systems has added a new cloud-based toolkit to the company's OncoPeer interactive online forum, making development tools available for research that has the potential to lead to next-generation cancer treatment technologies.

Men with relatively unaggressive prostate tumors whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to a study from the Brady Urological Institute at Johns Hopkins.

DOPPLER-CIP trial, ESC 2015, heart failure, predictor, small left ventricle, University of Leuven

September 2, 2015 — Findings presented at the European Society of Cardiology (ESC) Congress 2015 indicate that a small left ventricle with thick walls is the strongest predictor of morphologic remodeling in chronic ischemic heart disease patients. This morphologic remodeling — detected via stress imaging tests — is generally considered a first step toward heart failure.

Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical Imaging (PMI) with the 2015 European Frost & Sullivan Award for Technology Leadership.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now